Skip to search formSkip to main contentSkip to account menu

Torcitabine

Known as: L-Deoxycytidine 
A nucleoside inhibitor with activity against hepatitis B virus. Torcitabine is modified in vivo to its triphosphate form and acts as a competitive… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Cellular Pharmacology of the Anti-Hepatitis B Virus Agent β-l-2′,3′-Didehydro-2′,3′-Dideoxy-N4-Hydroxycytidine: Relevance for Activation in HepG2 Cells
ABSTRACT ß-l-2′,3′-Didehydro-2′,3′-dideoxy-N4-hydroxycytidine (l-Hyd4C) was demonstrated to be an effective and highly selective… 
Review
2004
Review
2004
Telbivudine/Torcitabine Idenix/Novartis.
Idenix (formerly Novirio) and Novartis are developing two beta-L-deoxynucleosides, telbivudine and torcitabine, for the potential… 
2004
2004
Telbivudine/Torcitabine Idenix/Novartis.
Idenix (formerly Novirio) and Novartis are developing two beta-L-deoxynucleosides, telbivudine and torcitabine, for the potential… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)